ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch

ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch

Key PointsENAVATE Added 157,800 shares of Zenas BioPharma worth an estimated $5.19 million (based on quarterly average price).The quarter-end position value increased by $58.80 million, reflecting both trading and stock price movement.The transaction represented a 1.02% change relative to the fund’s $506.78 million 13F reportable assets under management.After the trade, ENAVATE held 3,919,159 shares of Zenas BioPharma valued at $142.30 million a…